ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2275

Immunization  Status and Barriers in Childhood Rheumatic Diseases

Shine Vazhappilly1, Otto Vanderkooi2,3,4, Susanne Benseler3,5, Tommy Gerschman6, Nicole Johnson5, Nadia Luca5, Paivi Miettunen3,7, Dwaraka Veeramreddy8 and Heinrike Schmeling3,5, 1University of Calgary, Calgary, AB, Canada, 2Pediatrics/Alberta Children's Hospital;, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, 3Alberta Children's Hospital Research Institute/University of Calgary, Calgary, AB, Canada, 4Pathology and Laboratory Medincine & Microbiology Immunology & Infectious Diseases, Department of Pathology and Laboratory Medicine & Microbiology Immunology & Infectious Diseases/University of Calgary, Calgary, AB, Canada, 5Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, 6Alberta Children's Hospital, Calgary, AB, Canada, 7Department of Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, 8Department of Pediatrics/Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: pediatric rheumatology and vaccines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Systemic Juvenile Idiopathic Arthritis, Spondyloarthropathy and Miscellaneous Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

To determine the vaccination status of children with rheumatic diseases, and identify immunization knowledge of families and potential barriers to vaccination.

Methods

A cross-sectional study of children with rheumatic diseases followed at a tertiary care center outpatient clinic was performed between October 2013 and March 2014. Demographics, diagnosis and current treatments were obtained from health records. Children were considered immunosuppressed, if they were currently received corticosteroids, non-biologic or biologic disease-modifying agents. A unique provincial electronic database that records accurate vaccine history was used to obtain actual patient vaccination history. Perceived immunization barriers, concerns and knowledge regarding contraindications to vaccination, and sources of immunization information were captured from a patient/parent questionnaire. Descriptive statistical methods were used to analyze the data.

Results

A total of 82 children were recruited into the study. The median age was 11.7 years. The most common diagnoses were juvenile idiopathic arthritis (65%), systemic lupus erythematosus (9%), and juvenile dermatomyositis (5%). Fifty eight (71%) children were considered immunosuppressed.

Vaccination database: Patients received most recommended vaccines, with the exception of the Influenza (2013/2014) and Hepatitis B vaccines (recommended for age of 10 [grade 5] in Canada). Influenza was missed 40% of the time in the 1 – 3 years old group, 18% of the time in the 4 – 9 years old group, and 27% of the time in the 10 – 17 years old group. Hepatitis B was missed at a rate of 4% in the 10 – 17 years old group.

Patient/parent questionnaire: Nine patients reported previous adverse reactions to vaccination (Influenza [5], Measles, Mumps, and Rubella (MMR) [2], Hepatitis B [2] and Varicella [2]). In 38% at least one vaccination was withheld, most commonly for active disease (26%), recommendation against receiving vaccinations by health care provider (23%), uncertainty about whether or not a vaccine should be given (19%), concerns about disease flare (13%) and/or side effects post vaccination (5%). Several sources of information were utilized by patients and families for vaccination information, and satisfaction with this information was fairly high. Patients and parents identified the following information gaps: 1) risks and contraindications of vaccinations in childhood rheumatic diseases, 2) age-appropriate vaccination schedules and modalities, 3) best practice of vaccination documentation. Vaccination reminders were identified as useful, with several comments indicating that e-mail alerts, reminders, and a method to track this information would be useful.

Conclusion

The majority of children with rheumatic illnesses received the recommended vaccines. Immunization gaps were identified for Influenza and Hepatitis B. Knowledge regarding contraindications to vaccination is good. Concerns about perceived safety limit vaccination completeness.


Disclosure:

S. Vazhappilly,
None;

O. Vanderkooi,
None;

S. Benseler,
None;

T. Gerschman,
None;

N. Johnson,
None;

N. Luca,
None;

P. Miettunen,
None;

D. Veeramreddy,
None;

H. Schmeling,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immunization-status-and-barriers-in-childhood-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology